Reference:
SA Vaccine Injury Medco-Legal Study Group – SAVIMS. (2024, August 18). Statement on proposed emergency roll-out of vaccine program in Africa for monkeypox. Johannesburg, South Africa. Retrieved from www.savims.org.za
Summary:
The SA Vaccine Injury Medco-Legal Study Group (SAVIMS) has expressed significant concerns regarding the proposed emergency rollout of monkeypox vaccines in Africa, as announced by African CDC and WHO officials. They highlight the absence of scientifically validated vaccines for monkeypox and caution against the use of repurposed smallpox vaccines, which may present serious adverse effects. SAVIMS argues that informed consent cannot be assured under current circumstances, as potential recipients lack comprehensive understanding of the risks involved. They also challenge the classification of monkeypox as a public health emergency, asserting it is generally self-limiting and does not necessitate mass vaccination. Furthermore, SAVIMS questions the reliability of mortality statistics associated with monkeypox, advocating for independent audits of data collection methods. The group urges public caution regarding vaccine adoption, emphasising the ethical right to refuse medical interventions lacking proven safety and efficacy. They invite dialogue with health authorities on these matters to ensure that public health policies align with scientific evidence and ethical standards. This statement by SAVIMS is a call for transparency and rigorous scientific evaluation in the face of emerging health threats in Africa.